Global Corneal Transplant
Global Corneal Transplant

Corneal Transplant Comprehensive Study by Type (Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Limbal Stem Cell Transplant, Others), Indication (Fungal Corneal Ulcer, Bullous Keratopathy, Keratoconus, Keratitis, Corneal Stromal Dystrophies, Others), End-User (Hospital, Eye Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Others), Corneal Type (Human Donor, Artificial Cornea) Players and Region - Global Market Outlook to 2026

Corneal Transplant Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Jun 2021 Edition 212 Pages 223 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Corneal Transplant Market?

The cornea copes fine with minor injuries or abrasions. If the sensitive cornea is scratched, healthy cells slide over quickly and patch the injury before infection occurs and vision is affected. If the scratch penetrates the cornea more deeply, however, the healing process will take longer, sometimes leading to greater pain, blurred vision, tearing, redness, and extreme sensitivity to light. These symptoms require professional treatment. Deeper scratches also can cause corneal scarring, leading to a haze on the cornea that may greatly impair vision. during this case, a corneal graft could also be needed.

The market study is being classified by Type (Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Limbal Stem Cell Transplant and Others) and major geographies with country level break-up.

Ajl Ophthalmic SA (Spain), Corneat Vision (Israel), CryoLife Inc. (United States), Exactech, Inc. (United States), Keramed Inc. (United States), Lifeline Scientific (United States), Medtronic plc. (United States), Organogenesis Inc. (United States), Presbia plc. (Ireland), Florida Lions Eye Bank (United States), San Diego Eye Bank (United States) and Massachusetts Eye and Ear (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Aurolab (India) and CorneaGen (United States).

Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Corneal Transplant market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Corneal Transplant market by Type, Application and Region.

On the basis of geography, the market of Corneal Transplant has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Growing Geriatric Population Susceptible to Eye Diseases
  • Growing Awareness Regarding Eye Disease Diagnosis
  • Advantages Associated With Minimally Invasive Treatment Coupled With Growing Awareness Regarding Corneal Transplants That Provide Aesthetic Benefits

Market Trend
  • Investment in R&D Activities for Innovation & Scope of Improvement

Restraints
  • High Cost Associated With Cornea Implant Surgeries

Opportunities
  • Advancement in Technologies and Developing Healthcare Infrastructure
  • Presence of Skilled Healthcare Professionals

Challenges
  • Patient Preference for Effective Treatment



The CMGs are guidelines on the diagnosis and management of a range of common and rare, but important, eye conditions that present with varying frequency in primary and first contact care.

Key Target Audience
Eye Hospital, Medical Surgery Center, Medical Research Laboratories, R&D Companies, Market Research and Consulting Service Providers and Others

Frequently Asked Questions (FAQ):

1. Which factors would majorly drive the Corneal Transplant Market?
"Growing Geriatric Population Susceptible to Eye Diseases " is seen as one of major growth factors of Corneal Transplant Market in years to come.

2. Can we have customized study for Corneal Transplant Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

3. Which region will lead the Global Corneal Transplant Market?
will lead the Corneal Transplant Market.
Report Objectives / Segmentation Covered
By Type
  • Penetrating Keratoplasty
  • Endothelial Keratoplasty
  • Descemet Stripping Automated Endothelial Keratoplasty
  • Corneal Limbal Stem Cell Transplant
  • Others
By Indication
  • Fungal Corneal Ulcer
  • Bullous Keratopathy
  • Keratoconus
  • Keratitis
  • Corneal Stromal Dystrophies
  • Others

By End-User
  • Hospital
  • Eye Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Laboratories
  • Others

By Corneal Type
  • Human Donor
  • Artificial Cornea

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Geriatric Population Susceptible to Eye Diseases
      • 3.2.2. Growing Awareness Regarding Eye Disease Diagnosis
      • 3.2.3. Advantages Associated With Minimally Invasive Treatment Coupled With Growing Awareness Regarding Corneal Transplants That Provide Aesthetic Benefits
    • 3.3. Market Challenges
      • 3.3.1. Patient Preference for Effective Treatment
    • 3.4. Market Trends
      • 3.4.1. Investment in R&D Activities for Innovation & Scope of Improvement
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Corneal Transplant, by Type, Indication, End-User, Corneal Type and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Corneal Transplant (Value)
      • 5.2.1. Global Corneal Transplant by: Type (Value)
        • 5.2.1.1. Penetrating Keratoplasty
        • 5.2.1.2. Endothelial Keratoplasty
        • 5.2.1.3. Descemet Stripping Automated Endothelial Keratoplasty
        • 5.2.1.4. Corneal Limbal Stem Cell Transplant
        • 5.2.1.5. Others
      • 5.2.2. Global Corneal Transplant by: Indication (Value)
        • 5.2.2.1. Fungal Corneal Ulcer
        • 5.2.2.2. Bullous Keratopathy
        • 5.2.2.3. Keratoconus
        • 5.2.2.4. Keratitis
        • 5.2.2.5. Corneal Stromal Dystrophies
        • 5.2.2.6. Others
      • 5.2.3. Global Corneal Transplant by: End-User (Value)
        • 5.2.3.1. Hospital
        • 5.2.3.2. Eye Clinics
        • 5.2.3.3. Ambulatory Surgical Centers
        • 5.2.3.4. Diagnostic Laboratories
        • 5.2.3.5. Others
      • 5.2.4. Global Corneal Transplant by: Corneal Type (Value)
        • 5.2.4.1. Human Donor
        • 5.2.4.2. Artificial Cornea
      • 5.2.5. Global Corneal Transplant Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Corneal Transplant: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Ajl Ophthalmic SA (Spain)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Corneat Vision (Israel)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. CryoLife Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Exactech, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Keramed Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Lifeline Scientific (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Medtronic plc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Organogenesis Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Presbia plc. (Ireland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Florida Lions Eye Bank (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. San Diego Eye Bank (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Massachusetts Eye and Ear (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Corneal Transplant Sale, by Type, Indication, End-User, Corneal Type and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Corneal Transplant (Value)
      • 7.2.1. Global Corneal Transplant by: Type (Value)
        • 7.2.1.1. Penetrating Keratoplasty
        • 7.2.1.2. Endothelial Keratoplasty
        • 7.2.1.3. Descemet Stripping Automated Endothelial Keratoplasty
        • 7.2.1.4. Corneal Limbal Stem Cell Transplant
        • 7.2.1.5. Others
      • 7.2.2. Global Corneal Transplant by: Indication (Value)
        • 7.2.2.1. Fungal Corneal Ulcer
        • 7.2.2.2. Bullous Keratopathy
        • 7.2.2.3. Keratoconus
        • 7.2.2.4. Keratitis
        • 7.2.2.5. Corneal Stromal Dystrophies
        • 7.2.2.6. Others
      • 7.2.3. Global Corneal Transplant by: End-User (Value)
        • 7.2.3.1. Hospital
        • 7.2.3.2. Eye Clinics
        • 7.2.3.3. Ambulatory Surgical Centers
        • 7.2.3.4. Diagnostic Laboratories
        • 7.2.3.5. Others
      • 7.2.4. Global Corneal Transplant by: Corneal Type (Value)
        • 7.2.4.1. Human Donor
        • 7.2.4.2. Artificial Cornea
      • 7.2.5. Global Corneal Transplant Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Corneal Transplant: by Type(USD Million)
  • Table 2. Corneal Transplant Penetrating Keratoplasty , by Region USD Million (2015-2020)
  • Table 3. Corneal Transplant Endothelial Keratoplasty , by Region USD Million (2015-2020)
  • Table 4. Corneal Transplant Descemet Stripping Automated Endothelial Keratoplasty , by Region USD Million (2015-2020)
  • Table 5. Corneal Transplant Corneal Limbal Stem Cell Transplant , by Region USD Million (2015-2020)
  • Table 6. Corneal Transplant Others , by Region USD Million (2015-2020)
  • Table 7. Corneal Transplant: by Indication(USD Million)
  • Table 8. Corneal Transplant Fungal Corneal Ulcer , by Region USD Million (2015-2020)
  • Table 9. Corneal Transplant Bullous Keratopathy , by Region USD Million (2015-2020)
  • Table 10. Corneal Transplant Keratoconus , by Region USD Million (2015-2020)
  • Table 11. Corneal Transplant Keratitis , by Region USD Million (2015-2020)
  • Table 12. Corneal Transplant Corneal Stromal Dystrophies , by Region USD Million (2015-2020)
  • Table 13. Corneal Transplant Others , by Region USD Million (2015-2020)
  • Table 14. Corneal Transplant: by End-User(USD Million)
  • Table 15. Corneal Transplant Hospital , by Region USD Million (2015-2020)
  • Table 16. Corneal Transplant Eye Clinics , by Region USD Million (2015-2020)
  • Table 17. Corneal Transplant Ambulatory Surgical Centers , by Region USD Million (2015-2020)
  • Table 18. Corneal Transplant Diagnostic Laboratories , by Region USD Million (2015-2020)
  • Table 19. Corneal Transplant Others , by Region USD Million (2015-2020)
  • Table 20. Corneal Transplant: by Corneal Type(USD Million)
  • Table 21. Corneal Transplant Human Donor , by Region USD Million (2015-2020)
  • Table 22. Corneal Transplant Artificial Cornea , by Region USD Million (2015-2020)
  • Table 23. South America Corneal Transplant, by Country USD Million (2015-2020)
  • Table 24. South America Corneal Transplant, by Type USD Million (2015-2020)
  • Table 25. South America Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 26. South America Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 27. South America Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 28. Brazil Corneal Transplant, by Type USD Million (2015-2020)
  • Table 29. Brazil Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 30. Brazil Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 31. Brazil Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 32. Argentina Corneal Transplant, by Type USD Million (2015-2020)
  • Table 33. Argentina Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 34. Argentina Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 35. Argentina Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 36. Rest of South America Corneal Transplant, by Type USD Million (2015-2020)
  • Table 37. Rest of South America Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 38. Rest of South America Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 39. Rest of South America Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 40. Asia Pacific Corneal Transplant, by Country USD Million (2015-2020)
  • Table 41. Asia Pacific Corneal Transplant, by Type USD Million (2015-2020)
  • Table 42. Asia Pacific Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 43. Asia Pacific Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 44. Asia Pacific Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 45. China Corneal Transplant, by Type USD Million (2015-2020)
  • Table 46. China Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 47. China Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 48. China Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 49. Japan Corneal Transplant, by Type USD Million (2015-2020)
  • Table 50. Japan Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 51. Japan Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 52. Japan Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 53. India Corneal Transplant, by Type USD Million (2015-2020)
  • Table 54. India Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 55. India Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 56. India Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 57. South Korea Corneal Transplant, by Type USD Million (2015-2020)
  • Table 58. South Korea Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 59. South Korea Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 60. South Korea Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 61. Taiwan Corneal Transplant, by Type USD Million (2015-2020)
  • Table 62. Taiwan Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 63. Taiwan Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 64. Taiwan Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 65. Australia Corneal Transplant, by Type USD Million (2015-2020)
  • Table 66. Australia Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 67. Australia Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 68. Australia Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 69. Rest of Asia-Pacific Corneal Transplant, by Type USD Million (2015-2020)
  • Table 70. Rest of Asia-Pacific Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 71. Rest of Asia-Pacific Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 72. Rest of Asia-Pacific Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 73. Europe Corneal Transplant, by Country USD Million (2015-2020)
  • Table 74. Europe Corneal Transplant, by Type USD Million (2015-2020)
  • Table 75. Europe Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 76. Europe Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 77. Europe Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 78. Germany Corneal Transplant, by Type USD Million (2015-2020)
  • Table 79. Germany Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 80. Germany Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 81. Germany Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 82. France Corneal Transplant, by Type USD Million (2015-2020)
  • Table 83. France Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 84. France Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 85. France Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 86. Italy Corneal Transplant, by Type USD Million (2015-2020)
  • Table 87. Italy Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 88. Italy Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 89. Italy Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 90. United Kingdom Corneal Transplant, by Type USD Million (2015-2020)
  • Table 91. United Kingdom Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 92. United Kingdom Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 93. United Kingdom Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 94. Netherlands Corneal Transplant, by Type USD Million (2015-2020)
  • Table 95. Netherlands Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 96. Netherlands Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 97. Netherlands Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 98. Rest of Europe Corneal Transplant, by Type USD Million (2015-2020)
  • Table 99. Rest of Europe Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 100. Rest of Europe Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 101. Rest of Europe Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 102. MEA Corneal Transplant, by Country USD Million (2015-2020)
  • Table 103. MEA Corneal Transplant, by Type USD Million (2015-2020)
  • Table 104. MEA Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 105. MEA Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 106. MEA Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 107. Middle East Corneal Transplant, by Type USD Million (2015-2020)
  • Table 108. Middle East Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 109. Middle East Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 110. Middle East Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 111. Africa Corneal Transplant, by Type USD Million (2015-2020)
  • Table 112. Africa Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 113. Africa Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 114. Africa Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 115. North America Corneal Transplant, by Country USD Million (2015-2020)
  • Table 116. North America Corneal Transplant, by Type USD Million (2015-2020)
  • Table 117. North America Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 118. North America Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 119. North America Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 120. United States Corneal Transplant, by Type USD Million (2015-2020)
  • Table 121. United States Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 122. United States Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 123. United States Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 124. Canada Corneal Transplant, by Type USD Million (2015-2020)
  • Table 125. Canada Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 126. Canada Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 127. Canada Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 128. Mexico Corneal Transplant, by Type USD Million (2015-2020)
  • Table 129. Mexico Corneal Transplant, by Indication USD Million (2015-2020)
  • Table 130. Mexico Corneal Transplant, by End-User USD Million (2015-2020)
  • Table 131. Mexico Corneal Transplant, by Corneal Type USD Million (2015-2020)
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Corneal Transplant: by Type(USD Million)
  • Table 145. Corneal Transplant Penetrating Keratoplasty , by Region USD Million (2021-2026)
  • Table 146. Corneal Transplant Endothelial Keratoplasty , by Region USD Million (2021-2026)
  • Table 147. Corneal Transplant Descemet Stripping Automated Endothelial Keratoplasty , by Region USD Million (2021-2026)
  • Table 148. Corneal Transplant Corneal Limbal Stem Cell Transplant , by Region USD Million (2021-2026)
  • Table 149. Corneal Transplant Others , by Region USD Million (2021-2026)
  • Table 150. Corneal Transplant: by Indication(USD Million)
  • Table 151. Corneal Transplant Fungal Corneal Ulcer , by Region USD Million (2021-2026)
  • Table 152. Corneal Transplant Bullous Keratopathy , by Region USD Million (2021-2026)
  • Table 153. Corneal Transplant Keratoconus , by Region USD Million (2021-2026)
  • Table 154. Corneal Transplant Keratitis , by Region USD Million (2021-2026)
  • Table 155. Corneal Transplant Corneal Stromal Dystrophies , by Region USD Million (2021-2026)
  • Table 156. Corneal Transplant Others , by Region USD Million (2021-2026)
  • Table 157. Corneal Transplant: by End-User(USD Million)
  • Table 158. Corneal Transplant Hospital , by Region USD Million (2021-2026)
  • Table 159. Corneal Transplant Eye Clinics , by Region USD Million (2021-2026)
  • Table 160. Corneal Transplant Ambulatory Surgical Centers , by Region USD Million (2021-2026)
  • Table 161. Corneal Transplant Diagnostic Laboratories , by Region USD Million (2021-2026)
  • Table 162. Corneal Transplant Others , by Region USD Million (2021-2026)
  • Table 163. Corneal Transplant: by Corneal Type(USD Million)
  • Table 164. Corneal Transplant Human Donor , by Region USD Million (2021-2026)
  • Table 165. Corneal Transplant Artificial Cornea , by Region USD Million (2021-2026)
  • Table 166. South America Corneal Transplant, by Country USD Million (2021-2026)
  • Table 167. South America Corneal Transplant, by Type USD Million (2021-2026)
  • Table 168. South America Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 169. South America Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 170. South America Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 171. Brazil Corneal Transplant, by Type USD Million (2021-2026)
  • Table 172. Brazil Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 173. Brazil Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 174. Brazil Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 175. Argentina Corneal Transplant, by Type USD Million (2021-2026)
  • Table 176. Argentina Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 177. Argentina Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 178. Argentina Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 179. Rest of South America Corneal Transplant, by Type USD Million (2021-2026)
  • Table 180. Rest of South America Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 181. Rest of South America Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 182. Rest of South America Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 183. Asia Pacific Corneal Transplant, by Country USD Million (2021-2026)
  • Table 184. Asia Pacific Corneal Transplant, by Type USD Million (2021-2026)
  • Table 185. Asia Pacific Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 186. Asia Pacific Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 187. Asia Pacific Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 188. China Corneal Transplant, by Type USD Million (2021-2026)
  • Table 189. China Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 190. China Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 191. China Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 192. Japan Corneal Transplant, by Type USD Million (2021-2026)
  • Table 193. Japan Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 194. Japan Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 195. Japan Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 196. India Corneal Transplant, by Type USD Million (2021-2026)
  • Table 197. India Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 198. India Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 199. India Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 200. South Korea Corneal Transplant, by Type USD Million (2021-2026)
  • Table 201. South Korea Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 202. South Korea Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 203. South Korea Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 204. Taiwan Corneal Transplant, by Type USD Million (2021-2026)
  • Table 205. Taiwan Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 206. Taiwan Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 207. Taiwan Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 208. Australia Corneal Transplant, by Type USD Million (2021-2026)
  • Table 209. Australia Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 210. Australia Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 211. Australia Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 212. Rest of Asia-Pacific Corneal Transplant, by Type USD Million (2021-2026)
  • Table 213. Rest of Asia-Pacific Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 214. Rest of Asia-Pacific Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 215. Rest of Asia-Pacific Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 216. Europe Corneal Transplant, by Country USD Million (2021-2026)
  • Table 217. Europe Corneal Transplant, by Type USD Million (2021-2026)
  • Table 218. Europe Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 219. Europe Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 220. Europe Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 221. Germany Corneal Transplant, by Type USD Million (2021-2026)
  • Table 222. Germany Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 223. Germany Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 224. Germany Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 225. France Corneal Transplant, by Type USD Million (2021-2026)
  • Table 226. France Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 227. France Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 228. France Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 229. Italy Corneal Transplant, by Type USD Million (2021-2026)
  • Table 230. Italy Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 231. Italy Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 232. Italy Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 233. United Kingdom Corneal Transplant, by Type USD Million (2021-2026)
  • Table 234. United Kingdom Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 235. United Kingdom Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 236. United Kingdom Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 237. Netherlands Corneal Transplant, by Type USD Million (2021-2026)
  • Table 238. Netherlands Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 239. Netherlands Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 240. Netherlands Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 241. Rest of Europe Corneal Transplant, by Type USD Million (2021-2026)
  • Table 242. Rest of Europe Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 243. Rest of Europe Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 244. Rest of Europe Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 245. MEA Corneal Transplant, by Country USD Million (2021-2026)
  • Table 246. MEA Corneal Transplant, by Type USD Million (2021-2026)
  • Table 247. MEA Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 248. MEA Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 249. MEA Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 250. Middle East Corneal Transplant, by Type USD Million (2021-2026)
  • Table 251. Middle East Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 252. Middle East Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 253. Middle East Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 254. Africa Corneal Transplant, by Type USD Million (2021-2026)
  • Table 255. Africa Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 256. Africa Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 257. Africa Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 258. North America Corneal Transplant, by Country USD Million (2021-2026)
  • Table 259. North America Corneal Transplant, by Type USD Million (2021-2026)
  • Table 260. North America Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 261. North America Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 262. North America Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 263. United States Corneal Transplant, by Type USD Million (2021-2026)
  • Table 264. United States Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 265. United States Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 266. United States Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 267. Canada Corneal Transplant, by Type USD Million (2021-2026)
  • Table 268. Canada Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 269. Canada Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 270. Canada Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 271. Mexico Corneal Transplant, by Type USD Million (2021-2026)
  • Table 272. Mexico Corneal Transplant, by Indication USD Million (2021-2026)
  • Table 273. Mexico Corneal Transplant, by End-User USD Million (2021-2026)
  • Table 274. Mexico Corneal Transplant, by Corneal Type USD Million (2021-2026)
  • Table 275. Research Programs/Design for This Report
  • Table 276. Key Data Information from Secondary Sources
  • Table 277. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Corneal Transplant: by Type USD Million (2015-2020)
  • Figure 5. Global Corneal Transplant: by Indication USD Million (2015-2020)
  • Figure 6. Global Corneal Transplant: by End-User USD Million (2015-2020)
  • Figure 7. Global Corneal Transplant: by Corneal Type USD Million (2015-2020)
  • Figure 8. South America Corneal Transplant Share (%), by Country
  • Figure 9. Asia Pacific Corneal Transplant Share (%), by Country
  • Figure 10. Europe Corneal Transplant Share (%), by Country
  • Figure 11. MEA Corneal Transplant Share (%), by Country
  • Figure 12. North America Corneal Transplant Share (%), by Country
  • Figure 13. Global Corneal Transplant share by Players 2020 (%)
  • Figure 14. Global Corneal Transplant share by Players (Top 3) 2020(%)
  • Figure 15. Global Corneal Transplant share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Ajl Ophthalmic SA (Spain) Revenue, Net Income and Gross profit
  • Figure 18. Ajl Ophthalmic SA (Spain) Revenue: by Geography 2020
  • Figure 19. Corneat Vision (Israel) Revenue, Net Income and Gross profit
  • Figure 20. Corneat Vision (Israel) Revenue: by Geography 2020
  • Figure 21. CryoLife Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. CryoLife Inc. (United States) Revenue: by Geography 2020
  • Figure 23. Exactech, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Exactech, Inc. (United States) Revenue: by Geography 2020
  • Figure 25. Keramed Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Keramed Inc. (United States) Revenue: by Geography 2020
  • Figure 27. Lifeline Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 28. Lifeline Scientific (United States) Revenue: by Geography 2020
  • Figure 29. Medtronic plc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Medtronic plc. (United States) Revenue: by Geography 2020
  • Figure 31. Organogenesis Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Organogenesis Inc. (United States) Revenue: by Geography 2020
  • Figure 33. Presbia plc. (Ireland) Revenue, Net Income and Gross profit
  • Figure 34. Presbia plc. (Ireland) Revenue: by Geography 2020
  • Figure 35. Florida Lions Eye Bank (United States) Revenue, Net Income and Gross profit
  • Figure 36. Florida Lions Eye Bank (United States) Revenue: by Geography 2020
  • Figure 37. San Diego Eye Bank (United States) Revenue, Net Income and Gross profit
  • Figure 38. San Diego Eye Bank (United States) Revenue: by Geography 2020
  • Figure 39. Massachusetts Eye and Ear (United States) Revenue, Net Income and Gross profit
  • Figure 40. Massachusetts Eye and Ear (United States) Revenue: by Geography 2020
  • Figure 41. Global Corneal Transplant: by Type USD Million (2021-2026)
  • Figure 42. Global Corneal Transplant: by Indication USD Million (2021-2026)
  • Figure 43. Global Corneal Transplant: by End-User USD Million (2021-2026)
  • Figure 44. Global Corneal Transplant: by Corneal Type USD Million (2021-2026)
  • Figure 45. South America Corneal Transplant Share (%), by Country
  • Figure 46. Asia Pacific Corneal Transplant Share (%), by Country
  • Figure 47. Europe Corneal Transplant Share (%), by Country
  • Figure 48. MEA Corneal Transplant Share (%), by Country
  • Figure 49. North America Corneal Transplant Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Ajl Ophthalmic SA (Spain)
  • Corneat Vision (Israel)
  • CryoLife Inc. (United States)
  • Exactech, Inc. (United States)
  • Keramed Inc. (United States)
  • Lifeline Scientific (United States)
  • Medtronic plc. (United States)
  • Organogenesis Inc. (United States)
  • Presbia plc. (Ireland)
  • Florida Lions Eye Bank (United States)
  • San Diego Eye Bank (United States)
  • Massachusetts Eye and Ear (United States)
Additional players considered in the study are as follows:
Aurolab (India) , CorneaGen (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation